Prognosis 'poor' in hepatic encephalopathy despite rifaximin therapy
Australian researchers emphasise the need to consider liver transplant in these patients
UPDATED: 11 June
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: